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Highlights 
 Powder suspension performance varied between batches of Fisher iron oxide 
I/1100/53 
 
 A greater number of particles <1 µm was measured in the more effective powder 
batch 
 
 Tween® 20 was shown to offer contingency if Triton™ X-100 becomes unavailable 
 
 The effectiveness of some iron oxides may vary between surfactant systems 
 
 A new Tween® 20 / iron oxide nanopowder (Sigma Aldrich) formulation is 
demonstrated 
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Abstract 
 
The effectiveness of the current UK iron oxide powder suspension formulation, ‘C-
IOPS-09’ (Triton X-100 based), for fingermark or latent fingerprint visualization is shown to 
be affected by variations between batches of the recommended iron oxide powder from 
Fisher Scientific (I/1100/53). When incorporated into the C-IOPS-09 formulation, a 2015 
powder batch resulted in the detection of ~19% fewer fingermarks, of broadly reduced 
contrast, when compared to powder suspension prepared with a 2008 batch of the same 
product. Furthermore, the 2015 powder batch was found to be unsuitable in experimental 
reduced-surfactant concentration powder suspension, because it caused surface-wide or 
background staining. The studies in this paper also investigated the use of Tween 20 
surfactant as an alternative to the currently utilised Triton X-100, in preparation for the 
potential unavailability of Triton X-100 in the future. Powder suspensions prepared with 
Tween 20 surfactant solutions of 4% and 40% were shown to offer similar effectiveness to 
the currently recommended C-IOPS-09 formulation, when compared using the same batch 
of Fisher Scientific iron oxide powder (2008 or 2015). The difference between the 2008 and 
2015 iron oxide batches was hence also evident with these alternative surfactant solutions. 
Particle size distribution analysis of the iron oxide powders in Tween 20 and Triton X-100 
based surfactant solutions show that the more effective powder exhibits a higher sub-
micrometre particle population than the less effective powder. This work leads to an 
improved specification for powder suspension formulations. This is demonstrated with an 
example powder suspension formulation which uses a 10% Tween 20 surfactant solution 
and iron oxide nanopowder (50 – 100 nm) from Sigma Aldrich, which was shown to visualise 
27% more fingermarks than the C-IOPS-09 formulation prepared with the 2015 Fisher 
Scientific powder batch, in a comparative study. 
  
 
1. Introduction 
 
The physico-chemical fingermark visualisation process ‘powder suspension’ is 
effective for use on non-porous and semi-porous surfaces in general [1, 2], and provides 
capability for fingermark detection on evidential items that have been exposed to water [1-3]. 
The process is encountered under other names in the field, including ‘wet powders’ [2], 
‘sticky-side powder’ and ‘thick powder suspension’ [4]. It is treated as a separate process to 
small particle reagent (SPR) in the Home Office Fingermark Visualisation Manual (FVM) [2]. 
The black iron (II/III) oxide powder suspension formulation published by the Home 
Office Centre for Applied Science and Technology (CAST) in 2009 [5] is currently 
recommended in the UK for treating light, non-adhesive surfaces [2]. The components of this 
formulation (‘C-IOPS-09’ - Appendix), which include iron (II/III) oxide powder and an 
aqueous ‘surfactant solution’ of Triton™ X-100 and ethylene glycol, were the subject of 
recent studies [6, 7]. It was demonstrated that the effectiveness of the formulation is strongly 
dependent on the iron (II/III) oxide powder product utilised [6]. 
The Fisher Scientific iron (II/III) oxide powder ‘I/1100/53’ (a general purpose material 
[8]) has been an effective powder for C-IOPS-09 [3, 6, 7, 9]. Scanning Electron Microscopy 
(SEM) analyses of fingermarks developed with iron oxide powder suspension prepared with 
this material showed that the particles adhering to the ridges ranged in size from a few 
hundred nanometres to one micrometre in diameter [10]. This information formed the basis 
for subsequent specifications for effective particle size for the process [3, 6]. An example 
SEM image highlighting the range of particle sizes on a fingermark developed with Fisher 
Scientific iron oxide (I/1100/53) powder suspension is shown in Figure 1. Other iron oxide 
particle parameters such as surface texture, coating and agglomeration behaviour have not 
been studied in relation to the efficacy of iron oxide powder suspension (C-IOPS-09 or 
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similar formulations), but have been shown to be important in other micro-sized powder, and 
powder suspension formulations [11, 12]. 
  
[Please place Fig. 1 here: single column size] 
 
Effective powder suspension formulations should selectively deposit powder on 
fingermark ridges and not the backgrounds of the surfaces to which they are applied. 
General ‘background staining’, caused by surface-wide powder deposition, is undesirable as 
it may reduce the contrast of visualised fingermark ridges [13, 14] and render fainter marks 
difficult to observe. Recently, the ‘fingermark selectivity’ exhibited by the C-IOPS-09 
formulation was shown to relate to the concentration of the surfactant Triton™ X-100 [7]. C-
IOPS-09 is prepared from a surfactant solution with a Triton™ X-100 concentration of > 400 
times the critical micelle concentration (c.m.c.) [7]. A powder suspension prepared using 
surfactant solution with Triton™ X-100 reduced to approximately the c.m.c. was shown to 
deposit iron oxide over the entire treated surface area of samples [7], whereas at ~2 × 
c.m.c., powder suspension did not cause background deposition in the study [7]. Triton™ X-
100 micelle structures form spontaneously at or above the c.m.c. [15], and hence the 
presence of micelles may be essential for visualising fingermark ridges without causing 
background staining [7]. It was also demonstrated that effective powder suspensions could 
be prepared with C-IOPS-09 surfactant solution diluted to 10% and 1%, and these 
formulations were advantageous in their ease of being rinsed off surfaces [7].  
It should be noted that additional processes can cause background staining effects to 
occur when powder suspensions are applied to incompatible surfaces. Known examples 
include C-IOPS-09 on acrylic-based adhesives such as some parcel tapes [2, 16] and 
carbon-based powder suspension on surfaces containing titanium dioxide, a common 
pigment in light coloured polymers [13].  
In general, a more detailed understanding of how powder particles interact with 
surfactant molecules would further our understanding of the powder suspension process [7], 
which is important for future process optimization and formulation resilience. 
The field of chemical fingermark visualisation has a history of formulation revisions 
driven by economic, environmental, and/or health and safety factors. Examples include the 
reformulation of ninhydrin working solution [17-19] due to the CFC bans in the mid 1990’s 
[18]; the replacement of Synperonic N surfactant with Tween® 20 in the U.S. Secret Service 
physical developer formulation [20, 21] due to the phase-out of nonylphenol ethoxylates [20]; 
and the development of a less-flammable methoxypropanol-based solvent black 3 
formulation for use at crime scenes [22, 23]. Recent work includes replacing HFE 
formulations for amino acid reagents [24]. 
Presently there is a risk associated with the C-IOPS-09 formulation, because the 
Triton™ X-100 surfactant belongs to the group of 4-(1,1,3,3-tetramethylbutyl)phenol 
ethoxylates residing on the Candidate List of Substances of Very High Concern [25, 26], as 
defined in article 57 of the REACH Regulation (European Commission) [27]. The concern is 
associated with the accumulation of 4-(1,1,3,3-tetramethylbutyl)phenol and the shorter chain 
ethoxylates in the environment, which are potential degradation products of the larger 
ethoxylates in the group (e.g. Triton™ X-100) [26]. Substances residing on the Candidate 
List may be placed on the Authorisation List (REACH) [28]. It is therefore possible that 
Triton™ X-100 will require authorisation in the European Union in the future, which may 
impact the permissible uses for the surfactant, and its availability. However, there is 
resilience for powder suspension, as researchers recently suggested an iron oxide powder 
suspension that is formulated utilising the Tween® 20 surfactant (Appendix) [29], however, 
the use of this has not been thoroughly assessed. 
This paper explores Tween® 20 iron oxide powder suspension formulations, including 
variation of concentration and comparisons with C-IOPS-09, and changes to the behaviour 
and effectiveness of different powders with surfactant formulation. 
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2. Materials and Methods 
 
Experiments 1 and 3 were relatively small-scale and concerned with exploring 
powder suspension components. These experiments were in line with ‘Phase 1’ or ‘proof of 
concept work’ as defined in the CAST Methodology [30] and the Guidelines for the 
Assessment of Fingermark Detection Techniques, by the International Fingerprint Research 
Group [31]. Experiments 2 and 4 compared powder suspension formulations using natural 
fingermarks and may be categorised as ‘Phase 2’ work as set out in the methodology papers 
[30, 31]. Phase 2 work is concerned with technique optimisation and is the phase preceding 
validation [31]. 
A selection of locally sourced non-porous substrates (Table 1) were acquired in new 
condition for these experiments, to challenge the iron oxide powder suspensions with 
operationally relevant surfaces with differing properties [30, 31]. Not all substrates were used 
for each experiment due to time and resource constraints, and the limitations associated with 
donating fingermarks for fair comparisons. 
 
 
Where substrates were cleaned (as specified), they were washed with warm tap 
water and detergent using a non-abrasive cloth. This was followed by successive rinsing 
with warm tap water (20 s), ethanol (5 s) and deionised water (5 s). Substrates were then 
allowed to air‒dry at room temp (15‒25°C). 
For natural fingermark donation, volunteers did not wash their hands for a minimum 
of 30 min before deposition and no eccrine or sebaceous loading was conducted [31]. 
Immediately prior to donation, volunteers rubbed their hands together to evenly distribute 
sweat and any environmental contaminants across all fingers. ‘Multiple donor’ and ‘depletion 
series’ fingermark collection methodologies were used [30], and are described in more detail 
by experiment. All fingermarks were aged in a laboratory environment (United Kingdom), out 
of direct sunlight.  
Powder suspensions were prepared fresh (before application) in each experiment, in 
a 1:1 w/v ratio (powder (g): surfactant solution (ml)) unless specified. Laboratory grade 
Triton™ X-100 (Sigma Aldrich, X100), ReagentPlus ≥99% ethylene glycol (Sigma Aldrich, 
324558), Tween® 20 (Sigma Aldrich, P1379) [32] and deionised water were utilized for the 
surfactant solutions (specific formulations given by experiment). Details for the iron (II/III) 
oxide powders investigated, as referenced in each experiment, are provided in Table 2. 
 
 
All powder suspensions in these studies were used as detailed in the Home Office 
FVM [2]. This included pre-wetting surfaces with tap water before applying powder 
suspensions using moistened squirrel-hair brushes, and leaving the suspensions on 
surfaces for approximately 10 s before rinsing off. Where different powder suspensions were 
compared in an experiment, separate clean squirrel-hair brushes were used for each. 
Visualised fingermarks were graded using a scheme published by the Home Office 
[30, 31] (see Table 3). All grading was conducted in a laboratory environment under 
reflected white light conditions, and directly from the substrates by eye. Only grade 3 and 4 
fingermarks were considered in the results analyses as they were deemed to be identifiable 
(although in some cases grade 2 marks may be sufficient for identification or exclusion). 
 
 
Further details for each individual experiment are provided on the following pages.  
 
2.1 Experiment 1 – factors affecting background staining 
 
This experiment was designed to further explore background staining with iron oxide 
powder suspension in relation to; the batch of iron oxide powder used; the surfactant 
solution concentration; and the cleanliness of substrates. 
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Powder suspensions were produced using three Triton™ X-100‒ethylene glycol 
surfactant solutions with different concentrations (as explored previously [7]) and two 
different batches of the recommended [9] I/1100/53 iron oxide powder product from Fisher 
Scientific (see Table 4 for details).  
All suspension were prepared form the same stock surfactant solution, with dilutions 
as shown in table 4. 
This experiment utilized a ‘spot-testing’ methodology: a pair of marked areas (30 x 60 
mm) on each substrate (1‒7, as per Table 1) was treated with each powder suspension: this 
size has been shown to be sufficient for analysis of substrate variation [13]. One marked 
area from each pair had been pre-cleaned on the day of the experiment, whilst the other had 
not been cleaned. There was no intentional fingermark deposition and visualisation 
incorporated into this study. 
 
 
2.2 Experiment 2 – Comparison between C-IOPS-09 and Tween® 20 powder suspension 
formulations 
 
The aim of this experiment was to compare the performance of the two iron oxide 
powder batches and compare C-IOPS-09 with iron oxide powder suspensions prepared with 
Tween® 20 surfactant solutions of different concentrations.  
C-IOPS-09 was compared to iron oxide powder suspensions produced with 40% 
Tween® 20 [29], 4% Tween® 20 and 0.66% Tween® 20 (~100 × c.m.c.) surfactant solutions. 
With the inclusion of both A and B iron oxides (Table 2), 8 different powder suspensions 
were compared overall (see Table 5). The 100 × c.m.c. (approx) Tween® 20 surfactant 
solution was created using volumetric glassware, and the c.m.c. was taken to be 0.06mM as 
per the manufacturer’s information [32] (similar values, e.g. 0.058mM, appear in the 
literature [35]).  
 
 
This experiment featured two substrate groups with different donors: 
- Group1: 
o Substrates 4, 7 and 9 (Table 1). 
o 7 donors (4 male, 3 female), aged 20‒40 (approx). 
- Group 2: 
o Substrates 5, 6 and 8 (Table 1). 
o 6 donors (3 male, 3 female), aged 20‒50 (approx). 
All substrate sheets except HDPE were pre-cleaned as described in section 2. HDPE 
preparation omitted this step because ethanol was observed to dissolve the printed inks.  
Fingermarks were donated on 8 sheets of substrate 4 – to create one sample for 
each of the 8 powder suspensions in the comparison. Donations were in depletion series of 
ten marks, and each donor contributed one depletion series per sheet, using a different 
finger each time. Donors then re-rubbed their hands together, and donated marks to create 
another set of 8 samples for substrate 7. This was then repeated for substrate 9, and these 
24 samples were aged for 7 days before being processed with the powder suspensions. On 
the same day but at a later time, this fingermark collection strategy was repeated to generate 
8 more samples each of substrates 4, 7 and 9. These 24 samples were aged 28 days before 
being processed. 
The above fingermark collection pattern was repeated on a different day for the 
group 2 substrates, to create further samples for aging 7 and 28 days. 
For this experiment, powder suspension preparation and processing were carried out 
on 4 separate days (representing the 2 substrate groups and 2 aging times). After 
processing, each sample was coded, and the treatment details were concealed so that 
pseudo blind grading could be undertaken by the primary experimenter. Half of the samples 
were re-graded blind by a second assessor who had no knowledge of the details of the 
comparison.   
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2.3 Experiment 3 – Scoping study for sub-micrometre iron oxide powders 
 
This experiment was designed to gauge whether iron oxide powders composed of 
sub-micrometre sized particles (as stated in the product specifications [33, 34]) perform 
more effectively in powder suspension than iron oxide powder B from Fisher Scientific.  
 Iron oxides B, C and D (table 2) were compared for use in C-IOPS-09 and powder 
suspension produced with 4% Tween® 20 surfactant solution (see table 6 for formulations).  
 
 
 
The C-IOPS-09 (B), (C) and (D) powder suspensions were prepared from the same 
stock surfactant solution. The 4% T20 (B), (C) and (D) powder suspensions were also 
prepared from the same stock surfactant solution (Table 6). 
This experiment utilized a multi-donor methodology [30]. On each substrate (3, 5 and 
8 (Table 1), all pre-cleaned, three sets of single fingermarks were collected (from 8 male and 
8 female donors, in the approximate age range of 21-60 years old) for processing with the C-
IOPS-09 (B), (C) and (D) powder suspensions (Table 6). Donors re-rubbed their hands 
together and repeated this donation pattern to create a set of samples to be processed with 
the 4% T20 (B), (C) and (D) powder suspensions. The fingermarks were aged for 7 days. 
 
2.4 Experiment 4 – Comparison between Tween 20 / sub-micrometre iron oxide powder 
suspension and C-IOPS-09 
 
 This experiment aimed to gauge the effectiveness of a powder suspension prepared 
with Tween 20 surfactant solution and sub-micrometre iron oxide (powder C) against the 
currently recommended C-IOPS-09 [2].  
C-IOPS-09 with iron oxide powder B was compared to iron oxide powder suspension 
produced with 10% Tween 20 surfactant solution and iron oxide powder C (table 7). The 
ratio for the novel Tween 20 and sub-micrometre iron oxide powder suspension was 1:2 w/v 
(powder (g): surfactant solution (ml)). 
 
Eighteen volunteers (9 male, 9 female) participated in this experiment, in the approximate 
age range of 20 to 50 years old. Two sets of samples were created using substrates 6, 7, 8 
and 10, with each volunteer donating fingermarks in depletions of 6, using a different finger 
each time. Donors re-rubed their hands and repeated this donation pattern to produce 2 sets 
of additional samples with substrates 3, 4, 5 and 9. The fingermarks were aged for seven 
days. One set of 8 substrate samples were processed with C-IOPS-09 (B) and the other set 
was processed with 10% T20 (C) (table 7).  
 
2.5 Iron oxide particle size analyses  
 
In support of these studies, iron oxide powders were analysed for particle size using a laser 
scattering particle sizer. Samples were prepared as an aliquot of dry powder, mixed with 10 
ml of 4% Tween® 20 in distilled water or 10 ml of C-IOPS-09 surfactant solution.  Samples 
were vortexed and a drop or series of drops from the prepared solution were analysed within 
a Malvern Mastersizer 3000E equipped with a small volume dispersion unit.  The amount of 
material added was selected to allow an obscuration within the instrument of 2-15%. The 
refractive index and density of the samples were assumed to be unvarying across the 
powders.  Each sample was measured for five consecutive 10 s periods and the process 
repeated.  Particles between 0.1 µm and 1000 µm are included in the analysis, grouped into 
100 size bins. Figures for each powder are normalized to 100%, and any possible particles 
outside the detection range are not included in the figures. 
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2.6 Health and Safety note 
 
Avoid the inhalation of iron oxide dust. Inhalation of particles below 10 µm can have an 
effect on asthma, other respiratory diseases, cardiovascular disease, and cancer.  The effect 
is stronger with particles below 2.5 µm in size, equivalent to fine particulate air pollution [36]. 
Additionally, magnetite particles with diameters of <~200 nm can be transported directly into 
the brain, where they may pose a hazard to human health [37].  
 
The Sigma Aldrich iron oxide product used in this work may be classified as a nanomaterial, 
and should be used with appropriate control measures. The need for further information 
regarding the effects of particulate nanomaterials on human health is widely acknowledged 
[38].  
 
 
3. Results 
3.1 Experiment 1 
The results of experiment 1 are represented in Figure 2. Expanded examples of full 
processed samples are provided in the Electronic Supplementary Information – ESI Fig. 1.   
 
[Please place Fig. 2 here: 1.5 column size] 
 
On ABS, painted steel (red), HDPE, and plastic board (4 of the 7 substrates), only 
1% surf sol (B) powder suspension caused background iron oxide deposition, and this was 
true for both the cleaned and unclean sample areas (Figure 2). However, for the ABS and 
HDPE, the background deposition was less pronounced on the cleaned sample areas. 
The 1% surf sol (B) powder suspension was not the only formulation to cause 
background staining on uPVC, painted steel (silver), and the wood-effect laminate, however, 
it caused more continuous and intense staining than the other formulations (Figure 2). 
The other iron oxide B powder suspensions ‒ 10% surf sol (B) and 100% surf sol (B) 
‒ did not cause background staining, other than some minor deposition on the wood-effect 
laminate and the uPVC (Figure 2). 
The 1% surf sol (A) powder suspension caused patchy deposition on the wood-effect 
laminate, uPVC and painted steel (silver) sample areas that had not been cleaned, and there 
was some just noticeable localised staining on the cleaned areas. Similar effects also 
occurred with the 10% surf sol (A) and 100% surf sol (A) suspensions (Figure 2), however, 
no iron oxide A powder suspension caused staining as intense or continuous as the 1% surf 
sol (B) powder suspension.  
 
 
3.2 Experiment 2: 
With the data for all substrates and both ageing periods combined, the results from 
experiment 2 (Figure 3) show that the iron oxide A powder suspensions recovered between 
536 marks (4% T20 (A)) and 580 marks (100×cmc T20 (A)), or 68.7% and 74.4% of the 
donated marks. The iron oxide B powder suspensions recovered between 338 (40% T20 
(B)) and 428 marks (C-IOPS-09 (B)), or 43.3% and 54.9% of the donated marks. 
 
[Please place Fig. 3 here: 1.5 column size] 
 
The appearance of the fingermark development achieved with powder suspensions 
prepared with iron oxide A was broadly equivalent. However, the 100×cmc T20 (A) powder 
suspension produced marks with more contrasting ridges for some donors, and occasionally 
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4% T20 (A) also yielded more contrasting marks for some donors than the C-IOPS-09 (A) 
and 40% T20 (A) powder suspensions. The appearance of visualised marks was also 
broadly similar between the iron oxide B powder suspensions C-IOPS-09 (B), 40% T20 (B) 
and 4% T20 (B). The development achieved using 100×cmc T20 (B), however, was 
characterised by darker ridges and significant background staining for most samples.  
The grouped data for Experiment 2 (Figure 3) indicates that each powder suspension 
formulation (C-IOPS-09, 40% T20, 4% T20 and 100×cmc T20) visualised more identifiable 
marks when prepared with iron oxide powder A than with powder B. The iron oxide B powder 
suspensions generally visualised fingermarks with weaker contrast than the corresponding 
iron oxide A powder suspensions (examples provided in Figures 4, and 5), although for 
some surfaces the difference was subtle. This overall trend was also true for each of the four 
sample sets (processed on the four separate days ‒ Table 8) when assessed independently.  
 
Considering the currently recommended formulation (C-IOPS-09) [2] only, the data 
shows a difference in fingermark recoverability of 19.2% between powder suspensions 
prepared with A and B iron oxide powders overall. A more detailed analysis of the difference 
between the iron oxides is achieved in considering the pairs of samples (the same substrate 
with a comparable set of fingermarks) processed with powder suspensions with common 
surfactant solutions. For example, C-IOPS-09 (A) recovered 61 marks, whereas C-IOPS-09 
(B) recovered 30 marks on the HDPE samples aged 7 days (see Table 8). Extending this 
analysis reveals that:  
 more fingermarks were detected by iron oxide A powder suspensions on 44/48 of the 
sample pairs 
 more fingermarks were detected by iron oxide A powder suspensions, with a 
difference of ≥10% of the deposited marks on 36/48 of the sample pairs 
 more fingermarks were detected by iron oxide A powder suspensions, with a 
difference of ≥25% of the deposited marks on 15/48 of the sample pairs 
 
[Please place Fig. 4 here: 2 column size] 
 
[Please place Fig. 5 here: 2 column size] 
 
The secondary assessor’s fingermark grade assignments (Electronic Supplementary 
Information – ESI Table 1) provided trends that were in broad similarity to those generated 
by the primary experimenter, for both the set 1 sample group (aged 7 days) and the set 2 
sample group (aged 28 days) (Figure 6). The trends from both individuals show that iron 
oxide A powder suspensions performed more effectively than iron oxide B powder 
suspensions. There is also similarity in the relative bar heights between most of the 
compared powder suspensions (Figure 6). Verifying trends in this way mitigates against any 
bias the primary experimenter may have had due to knowledge of the formulations.  
 [Please place Fig. 6 i here: single column size] 
[Please place Fig. 6 ii here: single column size] 
[Please place Fig. 6 iii here: single column size] 
[Please place Fig. 6 iv here: single column size] 
3.3 Experiment 3 
 
On grouping the data for the three substrates, the 4% T20 powder suspensions 
visualised between 41/48 and 42/48 of the donated marks to grade 3 or 4 quality, and the C-
IOPS-09 powder suspensions visualised between 37/48 and 41/48 of the marks to grade 3 
or 4 quality (Electronic Supplementary Information – ESI Table 2). This experiment was too 
small for meaning to be derived from the slight performance difference between the three 
powders, for both surfactant solutions. Of more interest is the visual appearance of the 
developed fingermarks. 
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Processing with the 4% T20 (C) and (D) powder suspensions resulted in more on-
mark iron oxide deposition than processing with 4% T20 (B) powder suspension (see Figure 
7). For a few donors, the ridge detail was obscured due to both on-ridge and inter-ridge 
powder deposition following the use of 4% T20 (C) and (D). The 4% T20 (C) powder 
suspension yielded marks that appeared darker than the marks visualised with other Tween® 
20 powder suspensions, and the 4% T20 (D) produced brownish marks (see Figure 7). 
These trends were true for all three substrates. 
Where the C-IOPS-09 surfactant solution was used, there were no noticeable 
differences observed in terms of amount of powder deposited on the marks between the 
powder suspensions (B), (C) and (D) (see Figure 7). There was no clear difference in 
visualised mark contrast between C-IOPS-09 (B) and C-IOPS-09 (C) powder suspensions, 
and C-IOPS-09 (D) produced brownish marks. These observations were consistent for all 
three substrates. 
 
[Please place Fig. 7 here: 1.5 column size]         
 
3.4 Experiment 4 
On grouping the data for the eight substrates, the 10% T20 (C) powder suspension 
visualised 599 of the donated marks (69.3%) and the C-IOPS-09 (B) powder suspension 
visualised 365 of the marks (42.2%), to grade 3 or 4 quality (Table 9). The 10% T20 powder 
suspension was also more effective on each surface individually (Table 9). 
 
 
 
 
The C-IOPS-09 (B) powder suspension predominantly visualised fingermarks with 
weaker contrast than the 10% T20 (C) powder suspension (examples provided in Figure 8). 
This contrast difference was obvious for most surfaces, except for the ceramic tile and 
HDPE surfaces where it was only apparent on closer examination of the fingermarks. Of the 
marks visualised with 10% T20 (C), up to 2% appeared over-developed, with some inter-
ridge iron oxide deposition. 
 
(i) [Please place Fig. 8 here: 1.5 column size]         
(ii) [Please place Fig. 8 here: 1.5 column size]         
 
3.5 Iron oxide analyses 
 
Particle size results are shown in Figure 9 and cumulative volume fraction is summarised in 
Table 10.  The measured particle size will be reflective of original dry size, expansion in the 
solution and agglomeration of particles. In 4% Tween® 20 solution iron oxide powder A has 
the largest fraction of sub-micrometre particles, with 14.4% as opposed to 5.7% for iron 
oxide powder B and 7.4% for iron oxide C. However, in this detergent iron oxide C has 
approximately 98% of particles below 5 µm, compared with 79% for iron oxides A and B.  In 
C-IOPS-09 surfactant solution iron oxide A again shows the largest fraction of sub-
micrometre particles, with 13.2%, as opposed to 1.8% for iron oxide B and 0.8% for iron 
oxide C. 
The primary particle size for iron oxide A (in 4% Tween® 20 or C-IOPS-09 solution) is 1.7 
µm. For iron oxide C in Tween 20 it is 1.9 µm.  For iron oxide B the peak of smallest particle 
size is for particles around 1.8-2.5 µm, but this does not necessarily cover the bulk of the 
sample, with peaks of particles from 30 µm to a few hundred. In C-IOPS-09 surfactant 
solution the distribution is bimodal and there is clear distinction between the two size groups 
of particles giving clear absence of particles between ~5 and ~30 µm. The iron oxide A 
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powder in C-IOPS-09 surfactant solution has 92% of particles below 5 µm, as opposed to 
25% for iron oxide B, and the remaining particles are above 100 µm. The biomodality and 
difference between powders is less evident in Tween® 20 solution where there are long tails 
from the distribution peaks.   
 
 
4. Discussion 
 
In previous work [7], it was shown that the surfactant solution for C-IOPS-09 could be 
diluted to 10% and 1% without reducing the effectiveness of the resultant powder 
suspension, when prepared with Fisher Scientific iron oxide powder batch 0760600 (2008) 
[7]. This included no undesirable iron oxide background deposition when used to visualise 
donated fingermarks on cleaned surfaces [7]. The results from Experiment 1 in this paper 
indicate that the previous findings may have also related to the properties of the particular 
iron oxide batch used. In Experiment 1 (this paper), continuous background staining 
occurred on most of the cleaned surface areas treated with 1% surf sol (B) powder 
suspension (which used Fisher Scientific iron oxide lot 1409138, 2015) whereas minimal if 
any background staining was observed when cleaned areas were processed with 1% surf 
sol (A) powder suspension (which used the same powder batch as the previous work [7]: 
Fisher Scientific iron oxide 0760600, 2008). Most of the other powder suspensions in 
experiment 1 with higher surfactant concentrations did not cause background staining on the 
cleaned sample areas, and where they did, it was mostly minimal and discontinuous. 
Experiment 1 has therefore indicated that significant surface staining relates mainly 
to the use of a powder suspension composed of lot number 1409138 Fisher Scientific iron 
oxide powder (2015) and low concentration surfactant solution (C-IOPS-09 surfactant 
solution diluted to 1%). Surface cleanliness was also an influencing factor, since some 
powder suspensions caused greater staining on sample areas that had not been cleaned.  
Earlier works demonstrated the importance of the substrate properties in fingermark 
visualisation [10, 13], and Experiment 1 further highlights this, as the intensity of background 
staining caused by 1% surf sol (B) powder suspension also varied between materials (Figure 
2). 
In Experiment 2, Tween® 20 surfactant solutions of a range of concentrations were 
demonstrated to offer similar capability to C-IOPS-09 surfactant solution for use in powder 
suspension when the same iron oxide powder batch was used, in terms of the number of 
identifiable marks visualised. The 100×cmc T20 powder suspension may be the least ideal 
formulation to take forward, because it caused background deposition with iron oxide powder 
B and thus may be a less stable formulation. The 40% T20 and 4% T20 powder suspensions 
were similar in effectiveness, although the 40% T20 powder suspension was more difficult to 
apply and rinse off.   
The trends generated in Experiment 2 suggest that the differences between the 
powder batches (iron oxides A and B) had a greater impact on powder suspension 
effectiveness than the differences between the four surfactant solutions tested (Figures 3 
and 6). The reduced numbers of identifiable fingermarks recovered by iron oxide B powder 
suspensions likely relates to the observed reduction in the contrast of visualised marks, 
when compared to corresponding marks visualised by iron oxide A powder suspensions. 
The particle size distribution analysis shows that the percentage of sub-micrometre particles 
in suspension was less with iron oxide B (5.7%) than for iron oxide A (14.4%) in 4% Tween® 
20, and a similar trend was observed in C-IOPS-09. It is particles of this size that have been 
shown to be responsible for ridge visualisation in previous work [10] therefore the greater 
number of these particles in iron oxide A is likely to lead to increased deposition of particles 
on the fingermark ridge. This will lead to increased contrast and the observed increased 
mark quality, with development of 68.7% of marks at high quality (grade 3 or 4) with iron 
oxide A in 4% Tween® 20  compared to 47.1% for iron oxide B, as shown in Figure 3. The 
larger particles are likely to be washed off in the mark development protocol, or in some 
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cases may contribute to the background staining, the degree of which is likely to be 
substrate and surfactant dependent [10, 13].  
The difference in effectiveness between the two Fisher Scientific I/1100/53 iron oxide 
batches (powders A and B) shown in this paper was not observed by Downham et al. [6].  
However, that study concentrated on a comparison to considerably less effective iron oxides, 
restricted the surfactant to C-IOPS-09 and was overall limited-scale. 
The variation in behaviour between the batches of Fisher Scientific iron oxide 
I/1100/53 observed in these studies suggests that this product may lead to inconsistent C-
IOPS-09 performance in the operational setting. In experiment 2, powder B was 
demonstrated to be less effective than powder A in the currently recommended powder 
suspension formulation (C-IOPS-09) by approximately 19%, in terms of the recovery of 
identifiable fingermarks. The requirement for a more refined iron (II/III) oxide powder was 
hence considered. 
Experiment 3 provided an indication that 50-100 nm iron oxide nanopowder from 
Sigma Aldrich (powder C) and micronized Bayferrox 318M from Lanxess (powder D) 
provided greater on-ridge deposition than Fisher Scientific iron oxide (powder B) when 
incorporated into powder suspension prepared with 4% Tween® 20 solution. No difference in 
on-ridge deposition was observed between these powders when the C-IOPS-09 surfactant 
solution was used, which demonstrates that the fingermark visualisation potential of some 
iron oxides in powder suspension is dependent on the surfactant.  The observed variation in 
fingermark enhancement between iron oxides B and C in 4% T20 powder suspension, and 
their performance similarity in C-IOPS-09 powder suspension appear to be reflected in the 
particle size distribution data. In 4% Tween 20 surfactant solution, the percentage of iron 
oxide C sub-micrometre particles (7.4%) and sub 2 micrometre particles (59.8%) were 
shown to be greater than for iron oxide B (5.7% and 38.4% respectively), whereas in C-
IOPS-09 surfactant solution, the percentage of iron oxide C sub-micrometre particles (0.8%) 
and sub 2 micrometre particles (11.4%) were both similar to the values for iron oxide B. 
Iron oxides C and D in 4% Tween® 20 solution visualised some fingermarks with 
obscured detail in experiment 3. This may be because a 1:1 w/v powder suspension is 
excessive in powder when using iron oxides with higher percentages of fine particles. Of 
further interest is the brown colour of the fingermarks visualised with powder suspensions 
produced using iron oxide D. This colour difference, relative to the marks visualised with B 
and C iron oxide powder suspensions, may relate to other structural or chemical differences 
between the iron oxides not investigated in these studies.   
The final study in this paper tested a 10% Tween 20 powder suspension with iron 
oxide powder C (1:2 w/v) against the C-IOPS-09 formulation prepared with the less effective 
Fisher Scientific powder (B). The 10% T20 (C) formulation visualised ~27% more 
fingermarks to identifiable quality (grade 3 or 4) than C-IOPS-09 (B). The use of Tween 20 at 
10% dilution and half the usual load of iron oxide resulted in a powder suspension that was 
relatively easy to rinse off surfaces, and caused very few fingermarks (<2%) to be over-
developed. Iron oxide C is a finer grade material than Fisher Scientific I/1100/53, as the 
product specification quotes a particle size range of 50-100 nm (SEM) [33]. It is anticipated 
that this product is less likely to present inter-batch variability issues, such as those 
demonstrated for the Fisher Scientific product in this work. This formulation, 10% T20 (C), 
hence represents a potential replacement for C-IOPS-09 with Fisher Scientific iron oxide 
I/1100/53. This formulation will need to be tested further before it can be recommended for 
operational use. 
 
 
6. Conclusion 
 
The studies in this paper show that two different batches of the recommended Fisher 
Scientific iron (II/III) oxide powder (from 2008 and 2015) perform differently in powder 
suspension. Initially it was determined that the 2015 batch of powder was unsuitable for use 
in the 1% C-IOPS-09 powder suspension formulation [7] due to resultant background 
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staining. Furthermore, this batch was demonstrated to be less effective in the higher 
surfactant concentration C-IOPS-09 formulation (the iron oxide powder suspension currently 
recommended for operational use in the UK), because it visualised ~19% fewer fingermarks 
than powder suspension prepared with the 2008 powder in a comparative investigation. This 
difference in effectiveness is demonstrated to relate to the size distribution of the particles, 
particularly the quantity of particles between 0.5 µm and 1 µm, which are responsible for 
development of the fingermarks.  The volume fraction of particles in this size range was 
shown to be 14.4% for the 2008 batch and 5.7% for the 2015 batch. This type of inter-batch 
variability may cause inconsistent iron oxide powder suspension performance in the 
operational setting.  
The recently proposed 40% Tween® 20 surfactant solution [29] was demonstrated to 
be similarly effective to C-IOPS-09 surfactant solution when compared with the same batch 
of Fisher Scientific iron (II/III) oxide powder (2008 or 2015). However, a 4% Tween® 20 
surfactant was found to be equally effective and has advantages in ease of application.  
Thus, Tween® 20 offers contingency for the iron (II/III) oxide powder suspension process in 
the event that Triton™ X-100 becomes restricted for use in the near future.  
 Reflecting the findings of importance of concentration of particle size below 1 micron 
and potential for use of Tween 20, a new powder suspension formulation using 10% Tween 
20 surfactant solution and a Sigma Aldrich iron oxide nanopowder (50-100 nm), in the ratio 
of 1:2 w/v, was demonstrated to be 27% more effective than C-IOPS-09 prepared with the 
2015 batch of Fisher Scientific iron oxide. The iron oxide nanopowder incorporated into this 
new formulation is anticipated to be more consistent between batches than the Fisher 
Scientific material, however more extensive testing is required. Further exploration of 
alternative surfactant solutions are to be encouraged and optimum concentration may have 
to be tuned to the specific iron oxide powder product in use. 
 
 
Declarations of interest: none 
 
Declarations 
 
Declarations of interest: none 
 
This research did not receive any specific grant from funding agencies in the public, commercial, or 
not-for-profit sectors. 
 
 
Acknowledgements 
 
The authors would like to thank Simon Kentesber (Lanxess Limited) for help and advice with iron 
oxide materials.   
 
 
AC
CE
PT
ED
 M
AN
US
CR
IPT
 
Appendix  
2009 CAST Iron Oxide Powder Suspension (‘C-IOPS-09’) [5] 
20 g iron (II/III) oxide (precipitated) 
20 mL stock detergent (surfactant) sol. (% by volume):  
25% Triton™ X-100  
35% ethylene glycol  
40% deionized water 
 
Australian Iron Oxide Powder Suspension [29] 
20 g iron (II/III) oxide (precipitated) 
20 mL stock detergent (surfactant) sol. (% by volume):  
40% Tween® 20  
60% deionized water 
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Figure 1 SEM image showing iron oxide particles on the ridge of a powder 
suspension-visualised fingermark, ranging from c.300 nm to 1 µm in diameter (with one 
particle above 1 µm). 
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Figure  2 Relative surface staining of powder suspensions ‒ experiment 1 overview 
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Figure 3 Combined data for Experiment 2 (all surfaces, both fingermark ages), primary 
experimenter’s grades 
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Figure 4 Overviews of ceramic tile and glass samples (7-day-old marks, first 5 depletions) 
processed with C-IOPS-09 and 4% T20 powder suspensions. The iron oxide powder A 
formulations yielded more contrasting marks.  
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Figure 5 Comparable processed 28-day-old fingermarks on glass (same donor and depletion 
number) from Experiment 2. Fingermarks on the top row were visualsied with powder 
suspensions produced with powder A: (i) C-IOPS-09 (A), (ii) 40% T20 (A), (iii) 4% T20 (A), 
(iv) 100×cmc T20 (A). Fingermarks on the bottom row were visualised with powder 
suspensions produced with powder B: (v) C-IOPS-09 (B), (vi) 40% T20 (B), (vii) 4% T20 (B), 
(viii) 100×cmc T20 (B). 
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Figure 6 Trend comparison between the primary experimenter and secondary assessor for 
the set 1 sample group ((i) and (ii)) and the set 2 sample group ((iii) and (iv)). 
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Figure 7 Comparison of different iron oxides (B, C and D – see Table 2) in C-IOPS-09 and 
4% T20 powder suspensions on (i) ceramic tile and on (ii) painted steel (red).  
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Figure 8 Examples of fingermarks visualised by 10% T20 (C) powder suspension and 
corresponding fingermarks visualised with C-IOPS-09 (B), drawing upon different substrates 
and depletion numbers. (i) Donors A and R, (ii) donors E and Q 
 
.   
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 Figure 9 
Mean measured particle size from powder samples in 4% Tween® 20 solution showing 
volume fraction of the material as a function of particle size. 
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Table 1 
Substrate reference table. 
Designation Substrate Colour Experiment 
numbers 
involving this 
substrate  
Substrate 1 Acrylonitrile butadiene 
styrene (ABS) board 
White 1 
Substrate 2 Pale wood-effect laminate 
(‘Japanese beech’) 
Light brown 1 
Substrate 3 Painted and lacquered steel Red 1, 3, 4 
Substrate 4 High density polyethylene 
(HDPE) Tesco carrier bag 
White with blue and 
red print 
1, 2, 4 
Substrate 5 Unplasticized polyvinyl 
chloride (uPVC) 
White 1, 2, 3, 4 
Substrate 6 Painted and lacquered steel Silver 1, 2, 4 
Substrate 7 Plastic board Grey 1, 2, 4 
Substrate 8 Ceramic tile (gloss finish) White 2, 3, 4 
Substrate 9 Glass (clear, ‘pro tough’) Colourless 2, 4 
Substrate 10 HDPE Morrisons carrier bag White with green print 4 
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Table 2 
Iron oxide powder product details. The same container of each material was used 
throughout the experiments. 
Powder 
Reference 
Powder Product 
Name 
Manufacturer / 
Supplier 
CAS Number Additional Details 
A Iron oxide, pure, 
magnetic, precipitated 
Fisher Scientific 1317-61-9 Product code: I/1100/53 
Packing date: 14/08/2008 
Batch number: 0760600 
B Iron oxide, pure, 
magnetic, precipitated 
Fisher Scientific 1317-61-9 Product code: 10385990  
Manufacturer part number/code: 
I/1100/53 
Packing date: 09/03/2015 
Lot: 1409138 
C Iron (II/III) oxide, 
50‒100nm 
Sigma Aldrich 1317-61-9 Product number: 637106 
Product code: 1002164693 
Particle size: 50‒100 nm [33] 
Purchased: 2017 
Lot: MKBT3736V 
D Bayferrox 318M Lanxess / 
Bayferrox 
1317-61-9 Synthetic, predominant particle 
size ~0.2µm [34] 
Sample provided: 2017 
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Table 3 
Fingermark grading scheme. 
Score Level of detail 
0 No evidence of fingermark 
1 Evidence of contact but no fingermark ridge details 
2 Less than 1/3 of the fingermark ridge detail is present 
3 1/3 to 2/3 of the fingermark ridge detail is present 
4 Over 2/3 of the fingermark ridge detail is present 
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Table 4 
Powder suspension formulation details for Experiment 1 (surf sol = surfactant solution). 
Powder Suspension 
Reference 
Iron Oxide Powder  
(as per Table 2) 
Surfactant Solution 
100% surf sol (A) A C-IOPS-09 stock sol. (Appendix) 
100% surf sol (B) B 
10% surf sol (A) A 10 ml C-IOPS-09 stock sol. 
90 ml deionised water 10% surf sol (B) B 
1% surf sol (A) A 1 ml C-IOPS-09 stock sol. 
99 ml deionised water 1% surf sol (B) B 
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Table 5 
Powder suspension formulation details for Experiment 2. 
Powder Suspension 
Reference 
Iron Oxide Powder  
(as per Table 2) 
Surfactant Solution 
C-IOPS-09 (A) A C-IOPS-09 stock sol. (Appendix) 
C-IOPS-09 (B) B 
40% T20 (A) A 40 ml Tween® 20 
60 ml deionised water 40% T20 (B) B 
4% T20 (A) A 4 ml Tween® 20 
96 ml deionised water 4% T20 (B) B 
100×cmc T20 (A) A 100 ml solution of 0.737g Tween® 
20 in deionised water 100×cmc T20 (B) B 
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Table 6 
Powder suspension formulation details for Experiment 3. 
 
 
 
 
 
 
 
 
 
  
Powder Suspension 
Reference 
Iron Oxide Powder  
(as per Table 2) 
Surfactant Solution 
C-IOPS-09 (B) B C-IOPS-09 stock sol. (Appendix) 
C-IOPS-09 (C) C 
C-IOPS-09 (D) D 
4% T20 (B) B 4 ml  Tween® 20 
96 ml deionised water 4% T20 (C) C 
4% T20 (D) D 
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Table 7 
Powder suspension formulation details for Experiment 4. 
 
 
 
 
 
  
Powder Suspension 
Reference 
Iron Oxide Powder  
(as per Table 2) 
Surfactant Solution 
C-IOPS-09 (B) B C-IOPS-09 stock sol. (Appendix) 
10% T20 (C) C 10 ml  Tween® 20 
90 ml deionised water 
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Table 8 
The number of grade 3 and 4 fingermarks visualised by each powder suspension in 
Experiment 2, by substrate and ageing period, graded by the primary experimenter. 
Substrate 
group 
Fingermark 
aging 
period  
Substrate Powder suspensions (iron oxides A and B, Table 2) 
C-IOPS-09 40% T20 4% T20 100×cmc T20 
A B A B A B A B 
1 
7 days 
HDPE (Tesco) 61 30 52 22 41 45 47 50 
Plastic board 62 0 29 6 45 15 42 30 
Glass 31 28 66 22 42 39 48 31 
28 days 
HDPE (Tesco) 55 38 43 30 53 37 56 28 
Plastic board 35 31 64 13 53 9 54 10 
Glass 60 52 49 40 44 38 65 48 
2 
7 days 
uPVC 52 40 43 35 51 45 51 24 
Painted  steel (silver) 40 35 35 40 48 38 50 37 
Ceramic tile 37 40 40 31 39 26 36 34 
28 days 
uPVC 49 46 50 39 41 25 43 20 
Painted steel (silver) 40 39 39 25 39 30 38 19 
Ceramic tile 56 49 46 35 40 20 50 39 
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Table 8 
The number of grade 3 and 4 fingermarks visualised by each powder suspension in 
Experiment 2, by substrate and ageing period, graded by the primary experimenter. 
Substrate 
group 
Fingermark 
aging 
period  
Substrate Powder suspensions (iron oxides A and B, Table 2) 
C-IOPS-09 40% T20 4% T20 100×cmc T20 
A B A B A B A B 
1 
7 days 
HDPE (Tesco) 61 30 52 22 41 45 47 50 
Plastic board 62 0 29 6 45 15 42 30 
Glass 31 28 66 22 42 39 48 31 
28 days 
HDPE (Tesco) 55 38 43 30 53 37 56 28 
Plastic board 35 31 64 13 53 9 54 10 
Glass 60 52 49 40 44 38 65 48 
2 
7 days 
uPVC 52 40 43 35 51 45 51 24 
Painted  steel (silver) 40 35 35 40 48 38 50 37 
Ceramic tile 37 40 40 31 39 26 36 34 
28 days 
uPVC 49 46 50 39 41 25 43 20 
Painted steel (silver) 40 39 39 25 39 30 38 19 
Ceramic tile 56 49 46 35 40 20 50 39 
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Table 9 
The number of grade 3 and 4 fingermarks visualised by both powder suspensions in 
Experiment 4, by substrate. 
Substrate Number of grade 3&4 
fingermarks 
10% T20 (C) C-IOPS-09 (B) 
Painted steel (red) 77 38 
HDPE (Tesco) 75 27 
Upvc 48 33 
Painted steel (silver) 84 51 
Plastic board 64 40 
Ceramic tile 72 47 
Glass 94 71 
HDPE (Morrisons) 85 58 
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Table 10 
Mean volume fraction (%) of binned cumulative particle sizes of three powder formulations 
(A, B and C – see Table 2) in C-IOPS-09 and 4% Tween 20 solutions with standard error.  
Particle 
size              
C-IOPS-09 solution 4% Tween® 20 solution 
  A    B    C     A    B    C   
<1 µm  13.2 ± 1.8  1.8 ± 0.3  0.8 ± 0.2   14.4 ± 2.5  5.7 ± 1.2  7.4 ± 0.8  
<2 µm  68.8 ± 6.4  15.3 ± 0.7  11.4 ± 2.1   50.3 ± 7.7  38.4 ± 5.9  59.8 ± 3.3  
<5 µm  91.7 ± 8.3  25.5 ± 1.0  22.5 ± 3.8   78.7 ± 11.3  78.8 ± 10.4  98.3 ± 1.7  
<10 µm  91.7 ± 8.3  25.5 ± 1.0  22.5 ± 3.8   79.1 ± 11.3  79.9 ± 10.5  98.4 ± 1.6  
<20 µm  91.7 ± 8.3  25.5 ± 1.0  22.5 ± 3.8   79.4 ± 11.2  80.0 ± 10.5  98.4 ± 1.6  
<50 µm  91.7 ± 8.3  25.5 ± 1.0  22.6 ± 3.8   81.1 ± 10.9  82.5 ± 9.6  98.4 ± 1.6  
<100 µm  91.7 ± 8.3  27.6 ± 0.9  44.0 ± 5.4   84.6 ± 9.8  86.6 ± 8.6  98.5 ± 1.5  
<200 µm  92.0 ± 8.0  55.4 ± 1.1  72.0 ± 9.3   91.6 ± 6.7  91.8 ± 6.1  99.7 ± 0.3  
<500 µm  96.8 ± 3.2  89.3 ± 2.5  89.6 ± 3.7   97.9 ± 2.0  98.7 ± 1.2  100.0 ± 0.0  
>500 µm  3.1 ± 3.2  10.6 ± 2.5  10.4 ± 3.7   2.1 ± 2.0  1.3 ± 1.2  0.0 ± 0.0  
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